177 related articles for article (PubMed ID: 17114358)
21. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
[TBL] [Abstract][Full Text] [Related]
22. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
[TBL] [Abstract][Full Text] [Related]
23. Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study.
Thomas RS; Clewell HJ; Allen BC; Yang L; Healy E; Andersen ME
Mutat Res; 2012 Aug; 746(2):135-43. PubMed ID: 22305970
[TBL] [Abstract][Full Text] [Related]
24. Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen.
Seidel SD; Stott WT; Kan HL; Sparrow BR; Gollapudi BB
Int J Toxicol; 2006; 25(1):57-64. PubMed ID: 16510358
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
26. Discrimination for genotoxic and nongenotoxic carcinogens by gene expression profiling in primary mouse hepatocytes improves with exposure time.
Mathijs K; Brauers KJ; Jennen DG; Boorsma A; van Herwijnen MH; Gottschalk RW; Kleinjans JC; van Delft JH
Toxicol Sci; 2009 Dec; 112(2):374-84. PubMed ID: 19770486
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
Fielden MR; Adai A; Dunn RT; Olaharski A; Searfoss G; Sina J; Aubrecht J; Boitier E; Nioi P; Auerbach S; Jacobson-Kram D; Raghavan N; Yang Y; Kincaid A; Sherlock J; Chen SJ; Car B;
Toxicol Sci; 2011 Nov; 124(1):54-74. PubMed ID: 21813463
[TBL] [Abstract][Full Text] [Related]
28. [Toxicoproteomics: first experiences in a BMBF-study].
Kröger M; Hellmann J; Toldo L; Glückmann M; von Eiff B; Fella K; Kramer PJ
ALTEX; 2004; 21 Suppl 3():28-40. PubMed ID: 15057406
[TBL] [Abstract][Full Text] [Related]
29. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
30. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
31. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
[TBL] [Abstract][Full Text] [Related]
32. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
33. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
34. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
[TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.
Park HJ; Oh JH; Park SM; Cho JW; Yum YN; Park SN; Yoon DY; Yoon S
Arch Toxicol; 2011 Dec; 85(12):1627-40. PubMed ID: 21607683
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
37. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
[TBL] [Abstract][Full Text] [Related]
39. Identifying blood biomarkers for mood disorders using convergent functional genomics.
Le-Niculescu H; Kurian SM; Yehyawi N; Dike C; Patel SD; Edenberg HJ; Tsuang MT; Salomon DR; Nurnberger JI; Niculescu AB
Mol Psychiatry; 2009 Feb; 14(2):156-74. PubMed ID: 18301394
[TBL] [Abstract][Full Text] [Related]
40. Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parameters.
Oberemm A; Ahr HJ; Bannasch P; Ellinger-Ziegelbauer H; Glückmann M; Hellmann J; Ittrich C; Kopp-Schneider A; Kramer PJ; Krause E; Kröger M; Kiss E; Richter-Reichhelm HB; Scholz G; Seemann K; Weimer M; Gundert-Remy U
Toxicol Appl Pharmacol; 2009 Dec; 241(2):230-45. PubMed ID: 19716841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
